Gilead Sciences, Inc.

Gilead Sciences, Inc.verified

GILD

Price:

$122.62

Market Cap:

$152.13B

Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, an injection for intravenous use, for the treatment of coronavirus disease 2019; and Epclusa, Harvoni, Vosevi, Vemlidy, and Viread for the treatment of liver diseases. It also offers Yescarta, Tecartus, Trodelvy, and Zydelig products for the treatment of hematology, oncology, and cell therapy patients. In addition, the company provides Letairis, an ora...[Read more]

Industry

Drug Manufacturers - General

IPO Date

1992-01-22

Stock Exchange

NASDAQ

Ticker

GILD

The ROE as of December 2025 (TTM) for Gilead Sciences, Inc. (GILD) is 40.74%

According to Gilead Sciences, Inc.’s latest financial reports and current stock price. The company's current ROE is 40.74%. This represents a change of 304.66% compared to the average of 10.07% of the last 4 quarters.

Gilead Sciences, Inc. (GILD) Historical ROE (quarterly & annually)

How has GILD ROE performed in the past?

The mean historical ROE of Gilead Sciences, Inc. over the last ten years is 32.04%. The current 40.74% ROE has changed 27.17% with respect to the historical average. Over the past ten years (40 quarters), GILD's ROE was at its highest in in the March 2016 quarter at 26.62%. The ROE was at its lowest in in the March 2024 quarter at -23.78%.

Quarterly (TTM)
Annual

Average

32.04%

Median

24.36%

Minimum

0.68%

Maximum

97.70%

Gilead Sciences, Inc. (GILD) ROE by Quarter and Year

Discovering the peaks and valleys of Gilead Sciences, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 4.27%

Maximum Annual ROE = 97.70%

Minimum Annual Increase = -97.17%

Minimum Annual ROE = 0.68%

Quarterly (TTM)
Annual
YearROEChange
20242.48%-89.99%
202324.81%14.76%
202221.62%-26.83%
202129.55%4.27%
20200.68%-97.17%
201923.91%-6.25%
201825.51%12.66%
201722.64%-68.33%
201671.48%-26.84%
201597.70%24.55%

Gilead Sciences, Inc. (GILD) Average ROE

How has GILD ROE performed in the past?

The current ROE of Gilead Sciences, Inc. (GILD) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

16.30%

5-year avg

15.83%

10-year avg

32.04%

Gilead Sciences, Inc. (GILD) ROE vs. Peers

How is GILD’s ROE compared to its peers?

Gilead Sciences, Inc.’s ROE is less than Pfizer Inc. (10.91%), less than Amgen Inc. (96.19%), less than Sanofi (12.39%), less than Bristol-Myers Squibb Company (34.65%), less than GSK plc (37.40%), less than Merck & Co., Inc. (38.95%), less than Danaher Corporation (6.88%), less than Boston Scientific Corporation (12.80%), less than Novo Nordisk A/S (77.86%), less than Stryker Corporation (13.92%),

CompanyROEMarket cap
10.91%$146.12B
96.19%$183.17B
12.39%$119.14B
34.65%$105.76B
37.40%$98.75B
38.95%$253.56B
6.88%$162.74B
12.80%$144.86B
77.86%$213.32B
13.92%$139.33B

Build a custom stock screener for Gilead Sciences, Inc. (GILD) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Gilead Sciences, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Gilead Sciences, Inc. (GILD) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Gilead Sciences, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the ROE?

How can you use the ROE?

What is Gilead Sciences, Inc.'s ROE?

How is the ROE calculated for Gilead Sciences, Inc. (GILD)?

What is the highest ROE for Gilead Sciences, Inc. (GILD)?

What is the 3-year average ROE for Gilead Sciences, Inc. (GILD)?

What is the 5-year average ROE for Gilead Sciences, Inc. (GILD)?

How does the current ROE for Gilead Sciences, Inc. (GILD) compare to its historical average?